期刊文献+

Protein neddylation and its role in health and diseases

原文传递
导出
摘要 NEDD8(Neural precursor cell expressed developmentally downregulated protein 8)is an ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate through a process known as neddylation,catalyzed by the enzyme cascade,namely NEDD8 activating enzyme(E1),NEDD8 conjugating enzyme(E2),and NEDD8 ligase(E3).The substrates of neddylation are categorized into cullins and non-cullin proteins.Neddylation of cullins activates CRLs(cullin RING ligases),the largest family of E3 ligases,whereas neddylation of non-cullin substrates alters their stability and activity,as well as subcellular localization.Significantly,the neddylation pathway and/or many neddylation substrates are abnormally activated or over-expressed in various human diseases,such as metabolic disorders,liver dysfunction,neurodegenerative disorders,and cancers,among others.Thus,targeting neddylation becomes an attractive strategy for the treatment of these diseases.In this review,we first provide a general introduction on the neddylation cascade,its biochemical process and regulation,and the crystal structures of neddylation enzymes in complex with cullin substrates;then discuss how neddylation governs various key biological processes via the modification of cullins and non-cullin substrates.We further review the literature data on dysregulated neddylation in several human diseases,particularly cancer,followed by an outline of current efforts in the discovery of small molecule inhibitors of neddylation as a promising therapeutic approach.Finally,few perspectives were proposed for extensive future investigations.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2024年第5期1869-1904,共36页 信号转导与靶向治疗(英文)
基金 This work was funded in part by the National Key R&D Program of China(grants 2022YFC3401500 to Y.S.and Y.Z.,and 2021YFA1101000 to Y.S.) the National Natural Science Foundation of China(grants 92253203 and U22A20317 to Y.S.,92053117 and 81972591 to Y.Z.,82202838 to S.Z.,and 82102749 to Q.Y.) Zhejiang Provincial Natural Science Foundation of China(grant LD22H300003 to Y.S.,LZ22H160003 to Y.Z.) Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang(grant 2022R01002 to Y.S.).
  • 相关文献

参考文献21

二级参考文献180

  • 1Yang Liu,Xiaojia Liu,Na Zhang,Mingxiao Yin,Jingwen Dong,Qingxuan Zeng,Genxiang Mao,Danqing Song,Lu Liu,Hongbin Deng.Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5[J].Acta Pharmaceutica Sinica B,2020,10(12):2299-2312. 被引量:35
  • 2Qing Yu,Yihan Jiang,Yi Sun.Anticancer drug discovery by targeting cullin neddylation[J].Acta Pharmaceutica Sinica B,2020,10(5):746-765. 被引量:8
  • 3Komander D, Rape M. The ubiquitin code. Annu Rev Bio- them 2012; 81: 203-229.
  • 4Wickliffe KE, Williamson A, Meyer H J, Kelly A,, Rape M. Kll-linked ubiquitin chains as novel regulators of cell divi- sion. Trends Cell Bio12011 ; 21:656-663.
  • 5Newton K, Matsumoto ME, Wertz IE, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134:668-678.
  • 6Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. 2008; Cell 133:653-665.
  • 7Walczak H, Iwai K, Dikic I. Generation and physiological roles of linear ubiquitin chains. BMC Bio12012; 10:23-23.
  • 8Nijman SM, Luna-Vargas MP, Velds A, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773-786.
  • 9Komander D, Clague M J, Urbe S. Breaking the chains: struc- ture and function of the deubiquitinases. Nat Rev Mol Cell Bio12009; 10:550-563.
  • 10Popovic D, Vucic D, Dikic I. Ubiquitination in disease patho- genesis and treatment. Nat Med 2014; 20:1242-1253.

共引文献407

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部